Comparing the Effectiveness of Fluconazole and a New Medicine (FK463) in Preventing Fungal Infections in Bone Marrow Transplant Patients - Related Studies

Comparing the Effectiveness of Fluconazole and a New Medicine (FK463) in Preventing Fungal Infections in Bone Marrow Transplant Patients

This study has been completed.

Study NCT00001937. Last updated on March 3, 2008. Information provided by National Institutes of Health Clinical Center (CC)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Aspergillosis
		Candidiasis
		Fungemia
		Mycoses

2	Additional conditions recognized in this trial
		Infection

3	More general conditions related to this trial
		Inflammation
		Pathologic Processes
		Sepsis
		Systemic Inflammatory Response Syndrome

4	Interventions listed in this trial
		FK463
		Fluconazole

5	Additional drug interventions recognized in this trial
		Micafungin

6	More general drug interventions related to this trial
		Anti-Infective Agents
		Antifungal Agents
		Pharmacologic Actions
		Therapeutic Uses

7	Sponsors listed in this trial
		National Cancer Institute (NCI)